Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 716.23 million compared to CNY 693.45 million a year ago. Revenue was CNY 716.23 million compared to CNY 693.45 million a year ago.

Net income was CNY 84.1 million compared to CNY 77.97 million a year ago. Basic earnings per share from continuing operations was CNY 0.91 compared to CNY 0.91 a year ago. Diluted earnings per share from continuing operations was CNY 0.91 compared to CNY 0.8812 a year ago.